Mortality Prediction Using Trauma Scores

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAl-Nahrain University

About this trial

The goal of this prospective cohort study is to compare the predictive utility of the Injury Severity Score (ISS), New Injury Severity Score (NISS), Revised Trauma Score (RTS), and Trauma and Injury Severity Score (TRISS) in determining mortality outcomes among trauma patients admitted to the trauma and emergency department at Kadhimiya Educational Hospital in Baghdad.

The main questions it aims to answer are:

Which trauma scoring system provides the most accurate prediction of mortality? Are there specific trauma patient subgroups where one scoring system outperforms the others?

Participants will:

Be assessed using all four trauma scoring systems (ISS, NISS, RTS, and TRISS) upon admission to the trauma and emergency department.

Have their clinical outcomes, including mortality, length of hospital stay, ICU admission, and discharge status, monitored throughout their hospital stay to evaluate the accuracy and utility of each scoring system in predicting patient outcomes.

Eligibility criteria

Qualifiers

Trauma patients admitted to the emergency room (ER).

Documented injury data sufficient to calculate both the New Injury Severity Score (NISS) and the Injury Severity Score (ISS).

Trauma scores (ISS, NISS, Revised Trauma Score [RTS], and Trauma and Injury Severity Score [TRISS]) calculated within 12 hour of arrival to ensure timely predictions.

Informed consent provided by the patient or a legal guardian in cases of incapacity.

Disqualifiers

Under 18 years of age and pregnant women, due to differences in trauma management and scoring applicability.

Non-trauma cases, including patients with terminal illnesses or severe cognitive impairments, to maintain focus on trauma outcomes.

Incomplete trauma scoring, missing or incomplete medical records, and

patients not treated in the trauma or emergency department.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
College of Medicine - Al-Nahrain University Baghdad Iraq

Sponsors and collaborators

Al-Nahrain University

Lead sponsor